# Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery

> **NCT00415701** · PHASE4 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 130 (estimated)

## Conditions studied

- Coronary Artery Disease
- Mitral Valve Regurgitation

## Interventions

- **DRUG:** Etomidate
- **DRUG:** Propofol
- **DRUG:** Hydrocortisone
- **DRUG:** NaCl 0.9%
- **OTHER:** Tetracosactin

## Key facts

- **NCT ID:** NCT00415701
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2010-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00415701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00415701, "Effect of Etomidate on Hemodynamics and Adrenocortical Function After Cardiac Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00415701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*